Literature DB >> 33185867

Induction of Antigen-Independent Proliferation of Regulatory T-Cells by TNF Superfamily Ligands OX40L and GITRL.

Prabhakaran Kumar1, Zarema H Arbieva2, Mark Maienschein-Cline3, Balaji B Ganesh4, Suresh Ramasamy4, Bellur S Prabhakar5.   

Abstract

TNF receptor superfamily comprises many T-cell costimulatory receptors, including TNFRSF1, TNFRSF2, TNFRSF4 (OX40), TNFRSF9 (4-1BB), TNFRSF18 (GITR), and TNFRSF7 (CD27). Signaling through these costimulatory stimulatory receptors can promote conventional T-cell (Tconv) proliferation, and effector functions in an antigen-dependent manner. Thus, agonistic antibodies and ligands for OX40, 4-1BB, GITR, and CD27 have been tested for inducing T-cell-mediated antitumor responses in several cancers. However, recently emerging reports show critical role for TNFR signaling in regulatory T-cell (Treg) differentiation and expansion, which might suppress effector T-cell proliferation and functions. Here, we show preferential over expression of TNFR2, OX40, 4-1BB, and GITR in Treg cells over Tconv cells, and the ability of OX40L and GITRL to induce selective proliferation of Treg cells, but not Tconv cells, in an antigen-independent manner. We describe the standard protocols used for Affymetrix gene expression profiling, T-cell isolation, and Cell Trace Violet-based cell proliferation assay.

Entities:  

Keywords:  4-1BBL; Cell proliferation; GITRL; OX40L; TNF-α; Tregs

Mesh:

Substances:

Year:  2021        PMID: 33185867     DOI: 10.1007/978-1-0716-1130-2_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  GITR/GITRL reverse signalling modulates the proliferation of hepatic progenitor cells by recruiting ANXA2 to phosphorylate ERK1/2 and Akt.

Authors:  Yu He; Yufeng Pei; Kai Liu; Lin Liu; Yue Tian; Hongyi Li; Min Cong; Tianhui Liu; Hong Ma; Hong You; Jidong Jia; Dong Zhang; Ping Wang
Journal:  Cell Death Dis       Date:  2022-04-04       Impact factor: 8.469

Review 2.  Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities.

Authors:  Qingqing Xie; Pengfei Zhang; Yuanyuan Wang; Wuxuan Mei; Changchun Zeng
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

3.  Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignancies.

Authors:  Claudia Giampietri; Francesca Scatozza; Elena Crecca; Virginia Vigiano Benedetti; Pier Giorgio Natali; Antonio Facchiano
Journal:  J Transl Med       Date:  2022-10-12       Impact factor: 8.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.